Once you know the big pharmaceutical companies are spending a lot of money looking for glucagon receptor antagonists and testing them, and GIP receptor antagonists and testing them, it requires a lot of gusto, a lot of lunacy and craziness to say, nah, I believe all these big pharmaceutical companies are wrong, my lab is doing the opposite. But now, the sentiment has drastically shifted and many companies are looking to co-agonist drugs to achieve over 20%, or even close to 30% weight loss
Research looks into its use for peripheral neuropathy, multiple sclerosis-related pain, and other nerve damage
Surprisingly, we found that liraglutide could activate the PKA/CREB pathway and inhibit inflammation
patients should report any neck mass, difficulty swallowing, or persistent hoarseness
Make Your Appointment Today!